- Home
- GSK vs CRH Comparison
GSK vs CRH Comparison
Compare GSK & CRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- CRH
- Stock Information
- Founded
- GSK 1715
- CRH 1936
- Country
- GSK United Kingdom
- CRH Ireland
- Employees
- GSK 70200
- CRH N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- CRH Building Materials
- Sector
- GSK Health Care
- CRH Industrials
- Exchange
- GSK Nasdaq
- CRH Nasdaq
- Market Cap
- GSK 68.6B
- CRH 61.7B
- IPO Year
- GSK N/A
- CRH N/A
- Fundamental
- Price
- GSK $33.60
- CRH $93.57
- Analyst Decision
- GSK Hold
- CRH Strong Buy
- Analyst Count
- GSK 5
- CRH 11
- Target Price
- GSK $45.50
- CRH $105.55
- AVG Volume (30 Days)
- GSK 4.3M
- CRH 3.9M
- Earning Date
- GSK 02-05-2025
- CRH 02-16-2025
- Dividend Yield
- GSK 4.63%
- CRH 2.54%
- EPS Growth
- GSK N/A
- CRH 9.79
- EPS
- GSK 0.81
- CRH 4.98
- Revenue
- GSK $41,966,224,352.00
- CRH $35,387,000,000.00
- Revenue This Year
- GSK $6.50
- CRH $4.21
- Revenue Next Year
- GSK $4.54
- CRH $7.03
- P/E Ratio
- GSK $20.12
- CRH $18.80
- Revenue Growth
- GSK 5.59
- CRH 0.74
- 52 Week Low
- GSK $32.83
- CRH $65.74
- 52 Week High
- GSK $45.93
- CRH $104.23
- Technical
- Relative Strength Index (RSI)
- GSK 40.58
- CRH 30.69
- Support Level
- GSK $33.58
- CRH $97.36
- Resistance Level
- GSK $34.56
- CRH $100.06
- Average True Range (ATR)
- GSK 0.54
- CRH 1.89
- MACD
- GSK 0.01
- CRH -1.13
- Stochastic Oscillator
- GSK 17.28
- CRH 6.74
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About CRH CRH PLC
CRH is a global manufacturer of a range of building products used in construction projects, operating via a vertically integrated business model. The past decade has seen CRH transform into a leading building materials business, with increasing exposure to upstream building activities such as aggregates and cement. CRH's geographic footprint is mostly across developed markets. North America is CRH's largest market and accounts for 75% of EBITDA. The company is the largest producer of aggregates and asphalt in the US.